MedPath

A study of Ropivacaine heavy and Bupivacaine heavy in hypertensive patients undergoing surgery under spinal anaesthesia

Phase 4
Conditions
Health Condition 1: I131- Hypertensive heart and chronic kidney disease without heart failureHealth Condition 2: I131- Hypertensive heart and chronic kidney disease without heart failureHealth Condition 3: I119- Hypertensive heart disease withoutheart failureHealth Condition 4: I119- Hypertensive heart disease withoutheart failure
Registration Number
CTRI/2022/06/043360
Lead Sponsor
IGIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

hypertensive patients, controlled blood pressure both male and female of age group 25- 70 years undergoing surgery under spinal anaesthesia .

Exclusion Criteria

1.Patient refusal for procedure.

2.ASA grade > III, IV

3.Emergency Surgery

4.Immunocompromised patients

5.All contraindications for Regional

anaesthesia

1. Those with bleeding disorders and local sepsis.

2. Those on anticoagulant and antiplatelet agent.

3. Those allergic to amide anaesthetics.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Heart rate, Blood pressure, mean arterial pressure recordingsTimepoint: 1min, 3min, 5min, 10min,15min,30min, 45min, 60 min intraoperative and postoperative period.
Secondary Outcome Measures
NameTimeMethod
modified bromage score for motor block assessment, global patient satisfaction scale, and patient comfort scoreTimepoint: in the post operative period upto 3-4 hrs
© Copyright 2025. All Rights Reserved by MedPath